Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11400086 Method of reducing chemotherapy-induced neutropenia

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

George Kenneth Lloyd0

Lan Huang0

Ramon Mohanlal0

Date of Patent

August 2, 2022

0

Patent Application Number

164825470

Date Filed

February 1, 2018

0

Patent Citations

US Patent 10668063 Method of treating cancer associated with a RAS mutation

US Patent 10076518 Method of treating a brain tumor

US Patent 10155748 Plinabulin compositions

US Patent 10550104 Plinabulin compositions

US Patent 10238650 Method of treating cancer associated with a RAS mutation

US Patent 10569169 Data processing method and apparatus for network system

US Patent 10596169 Cancer treatment with combination of plinabulin and taxane

US Patent 11045467 Method of treating cancer associated with a RAS mutation

Patent Primary Examiner

Elly-Gerald Stoica

0

CPC Code

0

0

0

0

0

Disclosed herein are plinabulin and the use for reducing neutropenia. Some embodiments relate to reducing the docetaxel induced neutropenia using plinabulin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11400086 Method of reducing chemotherapy-induced neutropenia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool